Recruiting studies: Hepatitis E

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of AT-587 in Healthy Subjects
Phase 1 · 1 location(s) · Atea Pharmaceuticals, Inc. · NCT07728487 Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women
Phase 2 · 1 location(s) · International Vaccine Institute · NCT05808166 Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
Phase 2 · 8 location(s) · AusperBio Therapeutics Inc. · NCT07370207 Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
Phase 4 · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05182463 Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children
Phase 2 · 3 location(s) · International Vaccine Institute · NCT06306196 Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.